These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 18931474

  • 21. Induced sputum in interstitial lung diseases: novel insights in the diagnosis, evaluation and research.
    Economidou F, Samara KD, Antoniou KM, Siafakas NM.
    Respiration; 2009; 77(3):351-8. PubMed ID: 19092236
    [Abstract] [Full Text] [Related]

  • 22. Latent pulmonary inflammation in patients with systemic sclerosis.
    Sánchez-Vidaurre S, Simeón CP, Cruz MJ, Fonollosa V, Vilardell M, Morell F, Muñoz X.
    Arch Bronconeumol; 2012 Jan; 48(1):8-13. PubMed ID: 22133713
    [Abstract] [Full Text] [Related]

  • 23. Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease.
    Toungoussova O, Migliori GB, Foschino Barbaro MP, Esposito LM, Dragonieri S, Carpagnano GE, Salerno FG, Neri M, Spanevello A.
    Respir Med; 2007 Jul; 101(7):1543-8. PubMed ID: 17258444
    [Abstract] [Full Text] [Related]

  • 24. Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators.
    Kowal-Bielecka O, Kowal K, Distler O, Rojewska J, Bodzenta-Lukaszyk A, Michel BA, Gay RE, Gay S, Sierakowski S.
    Arthritis Rheum; 2005 Dec; 52(12):3783-91. PubMed ID: 16320329
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases.
    Petkova D, Xaubet A, Picado C, Filella X, Agusti C, Luburich P, Rodriguez-Roisin R.
    Respir Med; 2000 Apr; 94(4):345-9. PubMed ID: 10845432
    [Abstract] [Full Text] [Related]

  • 26. Bronchoalveolar lavage in interstitial lung diseases: does the recovery rate affect the results?
    Schildge J, Nagel C, Grun C.
    Respiration; 2007 Apr; 74(5):553-7. PubMed ID: 17496412
    [Abstract] [Full Text] [Related]

  • 27. Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease.
    Kowal-Bielecka O, Distler O, Kowal K, Siergiejko Z, Chwiećko J, Sulik A, Gay RE, Łukaszyk AB, Gay S, Sierakowski S.
    Arthritis Rheum; 2003 Jun; 48(6):1639-46. PubMed ID: 12794832
    [Abstract] [Full Text] [Related]

  • 28. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC, Highland KB, Silver RM, Strange C.
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [Abstract] [Full Text] [Related]

  • 29. Bronchoalveolar lavage cell composition in allogeneic bone marrow transplant patients without symptomatic lung complications.
    de la Cámara R, Girón R, Marrón C, Martínez C, Ancochea J, Fernández-Rañada JM, Aspa J.
    Bone Marrow Transplant; 1997 Dec; 20(12):1087-93. PubMed ID: 9466283
    [Abstract] [Full Text] [Related]

  • 30. [Changes in lymphocyte subsets in bronchoalveolar lavage fluid in patients with systemic sclerosis].
    Kopiński P, Nalepa P, Wojas-Pelc A, Janowska E, Gil K.
    Pol Merkur Lekarski; 2000 Jan; 7(43):18-22. PubMed ID: 10765646
    [Abstract] [Full Text] [Related]

  • 31. Comparison of induced sputum and bronchoalveolar lavage fluid cell profile during the treatment of pulmonary sarcoidosis.
    Mroz RM, Korniluk M, Stasiak-Barmuta A, Chyczewska E.
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):445-52. PubMed ID: 18204157
    [Abstract] [Full Text] [Related]

  • 32. A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease.
    Várai G, Earle L, Jimenez SA, Steiner RM, Varga J.
    J Rheumatol; 1998 Jul; 25(7):1325-9. PubMed ID: 9676764
    [Abstract] [Full Text] [Related]

  • 33. Alveolar macrophage subpopulations in bronchoalveolar lavage and induced sputum of asthmatic and control subjects.
    St-Laurent J, Turmel V, Boulet LP, Bissonnette E.
    J Asthma; 2009 Feb; 46(1):1-8. PubMed ID: 19191129
    [Abstract] [Full Text] [Related]

  • 34. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
    Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R.
    Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
    [Abstract] [Full Text] [Related]

  • 35. BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.
    Domagała-Kulawik J.
    Diagn Cytopathol; 2008 Dec; 36(12):909-15. PubMed ID: 18855907
    [Abstract] [Full Text] [Related]

  • 36. [Bronchoalveolar lavage in the diagnosis of diffuse interstitial lung disease].
    Drent M, Costabel U.
    Ned Tijdschr Geneeskd; 1998 Dec 05; 142(49):2661-5. PubMed ID: 10065220
    [Abstract] [Full Text] [Related]

  • 37. Role of bronchoalveolar lavage in the initial diagnosis of smoking-related interstitial lung diseases.
    Domagala-Kulawik J, Maskey-Warzechowska M, Krenke R, Chazan R.
    J Physiol Pharmacol; 2008 Dec 05; 59 Suppl 6():243-51. PubMed ID: 19218648
    [Abstract] [Full Text] [Related]

  • 38. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K, Krenke R, Domagala-Kulawik J, Korczynski P, Nejman-Gryz P, Kosciuch J, Hildebrand K, Chazan R.
    J Physiol Pharmacol; 2008 Dec 05; 59 Suppl 6():271-83. PubMed ID: 19218651
    [Abstract] [Full Text] [Related]

  • 39. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
    Marie I, Dominique S, Levesque H, Ducrotté P, Denis P, Hellot MF, Courtois H.
    Arthritis Rheum; 2001 Aug 05; 45(4):346-54. PubMed ID: 11501722
    [Abstract] [Full Text] [Related]

  • 40. Induced Sputum Analysis in Subjects With Systemic Sclerosis.
    Litinsky I, Fireman E, Paran D, Polachek A, Broide A, Sharabi A, Anouk M, Elkayam O.
    Respir Care; 2016 Oct 05; 61(10):1369-73. PubMed ID: 27274093
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.